Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial

Physical fitness, walking performance, and gait in multiple sclerosis

(2013) Brian M. Sandroff et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US

(2013) Michele Jara et al.   Neuropsychiatric Disease and Treatment

A phase 3 trial of extended release oral dalfampridine in multiple sclerosis

(2010) Andrew D. Goodman et al.   ANNALS OF NEUROLOGY

Postural Control in Multiple Sclerosis: Implications for Fall Prevention

(2010) Michelle H. Cameron et al.   Current Neurology and Neuroscience Reports

Multiple sclerosis and mobility-related assistive technology: Systematic review of literature

(2010) Ana Souza et al.   JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT

Contribution of impaired mobility to patient burden in multiple sclerosis

(2009) Matthew H. Sutliff   CURRENT MEDICAL RESEARCH AND OPINION

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial

(2009) Andrew D Goodman et al.   LANCET

Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable

(2008) C Heesen et al.   Multiple Sclerosis Journal